Runx3 expression in lymph nodes with metastasis is associated with the outcome of gastric cancer patients

Oncology Letters

Volumn 2, Issue 6, 2011, Pages 1275-1279

  Xu, Hong Wei ^a   Ren, Feng ^a   Yu, Yan Ming ^b   Cai, Cheng Zhong ^c  

^a Soochow University   (China)

^b Central Hospital of Huangpu District   (China)

^c TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Lymph node metastasis; Prognosis; Runx3; Stomach neoplasms

Indexed keywords

TRANSCRIPTION FACTOR RUNX3;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING;

EID: 80052710875     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.381     Document Type: Article

References (29)

1. Kamangar F, Dores GM and Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150, 2006.
2. Rohatgi PR, Yao JC, Hess K, et al: Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival. Cancer 107: 2576-2580, 2006.
3. Nashimoto A, Nakajima T, Furukawa H, et al: Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. J Clin Oncol 21: 2282-2287, 2003.
4. Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A and Roviello F: Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg 241: 247-255, 2005.
5. Deng JY, Sun D, Liu XY, Pan Y and Liang H: STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer. World J Gastroenterol 16: 5380-5387, 2010.
6. Tsang YH, Lamb A, Romero-Gallo J, et al: Helicobacter pylori Cag A targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation. Oncogene 29: 5643-5650, 2010.
7. Ito Y: Runx genes in development and cancer: regulation of viral gene expression and the discovery of Runx family genes. Adv Cancer Res 99: 33-76, 2008.
8. Ito K, Lim AC, Salto-Tellez M, et al: Runx3 attenuates β-catenin/T cell factors in intestinal tumourigenesis. Cancer Cell 14: 226-237, 2008.
9. Soong R, Shah N, Peh BK, et al: The expression of Runx3 in colorectal cancer is associated with disease stage and patient outcome. Br J Cancer 100: 676-679, 2009.
10. Mabuchi M, Kataoka H, Miura Y, et al: Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction. Biochem Biophys Res Commun 398: 321-325, 2010.
11. Wei D, Gong W, Oh SC, et al: Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis. Cancer Res 65: 4809-4816, 2005.
12. Li WQ, Pan KF, Zhang Y, et al: Relationship between Runx3 expression and precancerous gastric lesions in high-risk population. Beijing Da Xue Xue Bao 41: 348-352, 2009.
13. Li QL, Ito K, Sakakura C, et al: Causal relationship between the loss of Runx3 expression and gastric cancer. Cell 109: 113-124, 2002.
14. Li WQ, Pan KF, Zhang Y, et al: RUNX3 methylation and expression associated with advanced precancerous gastric lesions in a Chinese population. Carcinogenesis 32: 406-410, 2011.
15. Yano T, Ito K, Fukamachi H, et al: The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis. Mol Cell Biol 26: 4474-4488, 2006.
16. Ito K, Liu Q, Salto-Tellez M, et al: RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res 65: 7743-7750, 2005.
17. Nakanishi Y, Shiraha H, Nishina SI, et al: Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis. BMC Cancer 11: 3, 2011.
18. Subramaniam MM, Chan JY, Yeoh KG, Quek T, Ito K and Salto-Tellez M: Molecular pathology of RUNX3 in human carcinogenesis. Biochim Biophys Acta 1796: 315-331, 2009.
19. Ogasawara N, Tsukamoto T, Mizoshita T, et al: RUNX3 expression correlates with chief cell differentiation in human gastric cancers. Histol Histopathol 24: 31-40, 2009.
20. Peng Z, Wei D, Wang L, et al: RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer. Clin Cancer Res 12: 6386-6394, 2006.
21. Chang TL, Ito K, Ko TK, et al: Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells. Gastroenterology 138: 255-265, 2010.
22. Hsu PI, Hsieh HL, Lee J, et al: Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer. Ann Surg Oncol 16: 1686-1694, 2009.
23. Xu HW, Ren F, Chen W, Wang YJ: The influence of survival analysis on RUNX3 gene expression in the primary tumor of patients suffering from stomach carcinoma. Cancer Research on Prevention and Treatment, 2011 (E-pub ahead of print).
24. Ikeda Y, Saku M, Kishihara F and Maehara Y: Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg 92: 235-239, 2005.
25. Furukawa H, Imamura H and Kodera Y: The role of surgery in the current treatment of gastric carcinoma. Gastric Cancer 5: 13-16, 2002.
26. Zhang XP, Wang ZL, Tang L, Sun YS, Cao K and Gao Y: Support vector machine model for diagnosis of lymph node metastasis in gastric cancer with multidetector computed tomography: a preliminary study. BMC Cancer 11: 10, 2011.
27. Tajima Y, Murakami M, Yamazaki K, et al: Risk factors for lymph node metastasis from gastric cancers with submucosal invasion. Ann Surg Oncol 17: 1597-604, 2010.
28. Park TJ, Han SU, Cho YK, Paik WK, Kim YB and Lim IK: Methylation of O6-methylguaine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. Cancer 92: 2760-2768, 2001.
29. Chen Y, Wei X, Guo C, et al: Runx3 suppresses gastric cancer metastasis through inactivation of MM9 by up-regulation of TIMP-1. Int J Cancer: Dec, 2010 (E-pub ahead of print).